Financially, Gyre had cash and cash equivalents totaling $15.9 million as of September 30, 2024. For the third quarter of ...

In practical terms, it’s still October out there. The area to watch is a tropical wave merging with yet another Central ...

Last patient completed pivotal Phase 3 trial in CHB-associated liver fibrosis in the PRC with data expected in Q1 2025On track to initiate U.S.

November. The post The Next Hurricane in the Gulf Could Form in These Two Places, Experts Say appeared first on Mandatory.

The eruption of Hunga Tonga-Hunga Ha'apai (HTHH) in January 2022 ejected about 2.9 billion tons of volcanic material into the ...

With the formation of Patty in the remote North Atlantic over the weekend, the next name on the Atlantic list is Rafael.

Meteorologists are tracking a disturbance in the Caribbean that could become the Atlantic’s next — and perhaps last — named ...

Hurricane?! It's possible in early November. What Florida residents should know Yet another factor this time is the Central American Gyre, which is more active at the start and end of the season.

As the National Hurricane Center keeps its eyes on three tropical waves in the basin, AccuWeather predicts that the Central American Gyre could once again help spin up a tropical depression or ...

In trading on Friday, shares of Gyre Therapeutics Inc (Symbol: GYRE) crossed above their 200 day moving average of $14.43, changing hands as high as $14.83 per share. Gyre Therapeutics Inc shares ...

Gyre Therapeutics is a biopharmaceutical company headquartered in San Diego, CA, with a primary focus on the development and commercialization of F351 (Hydronidone) for the treatment of MASH ...

The National Hurricane Center is tracking an area of disturbed weather that has a 30% chance of developing into a cyclone over the next week deep in the Caribbean Sea. Currently, the atmospheric ...